Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Shares Outstanding (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Shares Outstanding for 4 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 766.53% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, up 766.53% year-over-year, with the annual reading at $4.5 million for FY2025, 766.53% up from the prior year.
  • Shares Outstanding for Q4 2025 was $4.5 million at bioAffinity Technologies, up from $3.5 million in the prior quarter.
  • The five-year high for Shares Outstanding was $17.8 million in Q1 2025, with the low at $313153.0 in Q4 2023.
  • Average Shares Outstanding over 4 years is $5.5 million, with a median of $4.0 million recorded in 2025.
  • The sharpest move saw Shares Outstanding crashed 96.26% in 2023, then surged 766.53% in 2025.
  • Over 4 years, Shares Outstanding stood at $8.4 million in 2022, then plummeted by 96.26% to $313153.0 in 2023, then skyrocketed by 65.78% to $519158.0 in 2024, then soared by 766.53% to $4.5 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $4.5 million, $3.5 million, and $939138.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.